The Journal of head trauma rehabilitation · 2024
Can Exposure Therapy Be Effective for Persistent Post-Concussion Symptoms? A Nonconcurrent Multiple Baseline Design Across 4 Cases.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hecker Lynn, King Skye, Stapert Sven, Geusgens Chantal, den Hollander Marlies, Fleischeuer Britt, van Heugten Caroline
Аннотация
OBJECTIVE: After a concussion, some patients develop persistent post-concussion symptoms, which interferes with functioning in daily life. A biopsychosocial explanation for the development and continuation of persistent post-concussion symptoms is the fear avoidance model (FAM). This study aimed to investigate the effectiveness and feasibility of an individual 14-week exposure therapy for patients with persistent symptoms after concussion.
PARTICIPANTS: Four participants from a medical psychology outpatient clinic participated in the study. Their age ranged between 51 and 68 years old ( M = 62.8, SD = 7). The average length of time since the concussion was 10 months.
DESIGN: A single-case experimental design (SCED) with nonconcurrent multiple baselines was used. Participants were randomly assigned to a baseline period (A phase) length between 21 and 42 days. The intervention phase (B phase) consisted of 14 treatment sessions in 14 weeks. The follow-up phase was 12 weeks.
MAIN MEASURES: Participants answered questions on a visual analogue scale about their satisfaction with functioning in daily life, avoidance behavior, and symptoms experience on a daily basis during baseline and on a weekly basis during intervention and follow-up. Additional outcomes included symptom severity, catastrophizing, quality of life, participation, avoidance behavior, and feasibility interviews.
RESULTS: Tau-U yielded significant effects ( P < .05) on all measures when comparing intervention and follow-up with the baseline in 3 out of 4 participants. Satisfaction with daily life increased and avoidance behavior and post-concussion symptoms experienced decreased. Participants and therapists rated the intervention protocol with an average of 8.8 out of 10.
CONCLUSION: The findings suggest that exposure therapy seems effective and feasible in treating patients with persistent symptoms after concussion in a clinical setting. Larger randomized controlled trials or replication with SCED studies are advised to obtain additional evidence on the effectiveness of exposure for individuals with persistent symptoms after concussion.
PARTICIPANTS: Four participants from a medical psychology outpatient clinic participated in the study. Their age ranged between 51 and 68 years old ( M = 62.8, SD = 7). The average length of time since the concussion was 10 months.
DESIGN: A single-case experimental design (SCED) with nonconcurrent multiple baselines was used. Participants were randomly assigned to a baseline period (A phase) length between 21 and 42 days. The intervention phase (B phase) consisted of 14 treatment sessions in 14 weeks. The follow-up phase was 12 weeks.
MAIN MEASURES: Participants answered questions on a visual analogue scale about their satisfaction with functioning in daily life, avoidance behavior, and symptoms experience on a daily basis during baseline and on a weekly basis during intervention and follow-up. Additional outcomes included symptom severity, catastrophizing, quality of life, participation, avoidance behavior, and feasibility interviews.
RESULTS: Tau-U yielded significant effects ( P < .05) on all measures when comparing intervention and follow-up with the baseline in 3 out of 4 participants. Satisfaction with daily life increased and avoidance behavior and post-concussion symptoms experienced decreased. Participants and therapists rated the intervention protocol with an average of 8.8 out of 10.
CONCLUSION: The findings suggest that exposure therapy seems effective and feasible in treating patients with persistent symptoms after concussion in a clinical setting. Larger randomized controlled trials or replication with SCED studies are advised to obtain additional evidence on the effectiveness of exposure for individuals with persistent symptoms after concussion.